A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis

L. K. Rocke, Charles Lawrence Loprinzi, J. K. Lee, S. J. Kunselman, R. K. Iverson, G. Finck, D. Lifsey, K. C. Glaw, B. A. Stevens, A. K. Hatfield, N. L. Vaught, J. Bartel, N. Pierson

Research output: Contribution to journalArticle

103 Scopus citations

Abstract

Background. The authors previously reported that 30 minutes of oral cryotherapy inhibits 5-fluorouracil (5-FU)-induced stomatitis. The current trial was designed to determine whether a longer duration of cryotherapy would provide additional protection. Methods. This trial involved patients who were receiving their first course of a 5-FU plus leucovorin chemotherapy regimen, for which stomatitis is a major dose-limiting toxicity. These patients were randomized to receive either 30 or 60 minutes of oral cryotherapy given at around the same time as the 5-FU therapy. Results. A total of 178 evaluable patients were studied. Both cryotherapy groups had similar degrees of mucositis. Conclusion. The authors continue to recommend the use of 30 minutes of oral cryotherapy for patients receiving bolus intensive courses of 5-FU-based chemotherapy.

Original languageEnglish (US)
Pages (from-to)2234-2238
Number of pages5
JournalCancer
Volume72
Issue number7
StatePublished - 1993

    Fingerprint

Keywords

  • 5-fluorouracil-induced mucositis
  • chemotherapy toxicity
  • mucositis
  • oral cryotherapy
  • stomatitis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Rocke, L. K., Loprinzi, C. L., Lee, J. K., Kunselman, S. J., Iverson, R. K., Finck, G., Lifsey, D., Glaw, K. C., Stevens, B. A., Hatfield, A. K., Vaught, N. L., Bartel, J., & Pierson, N. (1993). A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer, 72(7), 2234-2238.